HB 330 — The medical use of low-THC cannabis by patients with a m

90R1732 LHC-D By: Plesa H.B. No. 330 relating to the medical use of low-THC cannabis by patients with a medical condition that causes menstrual cramps.

SECTION 1. Section 169.003(a), Occupations Code, is amended to read as follows: (a) A physician described by Section 169.002 may prescribe low-THC cannabis to a patient if: (1) the patient is a permanent resident of the state; (2) the physician complies with the registration requirements of Section 169.004; and (3) the physician certifies to the department that: (A) the patient is diagnosed with: (i) epilepsy; (ii) a seizure disorder; (iii) multiple sclerosis; (iv) spasticity; (v) amyotrophic lateral sclerosis; (vi) autism; (vii) cancer; (viii) an incurable neurodegenerative disease; (ix) post-traumatic stress disorder; (x) a condition that causes chronic pain; (xi) traumatic brain injury; (xii) Crohn's disease or other inflammatory bowel disease; (xiii) a terminal illness or a condition for which a patient is receiving hospice or palliative care; [ or ] (xiv) a condition that causes menstrual cramps, including premenstrual dysphoric disorder or dysmenorrhea; or (xv) a medical condition that is approved for a research program under Subchapter F, Chapter 487, Health and Safety Code, and for which the patient is receiving treatment under that program; and (B) the physician determines the risk of the medical use of low-THC cannabis by the patient is reasonable in light of the potential benefit for the patient.

SECTION 2. This Act takes effect September 1, 2027.